Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IXIARO in elderly adults
2010-018630-52Phase 4Completed
- Sponsor
- Intercell AG
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Intercell AG. Primary endpoints: Rate of subjects with serious adverse events and medically attended adverse events and Immunogenicity of IXIARO. Started Apr 2010; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2010-018630-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018630-52.